4//SEC Filing
Niederhuber John 4
Accession 0000950170-24-068075
CIK 0001671584other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:58 PM ET
Size
10.6 KB
Accession
0000950170-24-068075
Insider Transaction Report
Form 4
Niederhuber John
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-01+7→ 136 total - Exercise/Conversion
Common Stock
2024-06-02+81→ 217 total - Exercise/Conversion
Restricted Stock Unit
2024-06-01−7→ 0 total→ Common Stock (7 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-06-02−81→ 0 total→ Common Stock (81 underlying)
Footnotes (4)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
- [F4]On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001501240
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:58 PM ET
- Size
- 10.6 KB